Q1 2026 Heartflow Inc Earnings Call Transcript
Key Points
- HeartFlow Inc (HTFL) reported a 41% year-over-year revenue increase in Q1 2026, reaching $52.6 million, driven by 67% global case growth.
- The company raised its full-year revenue guidance to $228 million to $232 million, representing 29% to 32% year-over-year growth.
- HeartFlow's Plaque Analysis product is outperforming expectations, leading to an increased revenue outlook of $19 million to $21 million for 2026.
- The company achieved a significant milestone by helping manage the care of over 650,000 patients worldwide, reinforcing its leadership position.
- HeartFlow's non-GAAP gross margin guidance was raised to approximately 81%, driven by AI efficiencies, volume leverage, and a higher mix of high-margin Plaque revenue.
- Despite strong performance, HeartFlow Inc (HTFL) remains in the early stages of Plaque adoption, with a need for continued medical education and market development.
- Operating expenses increased, with SG&A expenses reaching $38.3 million, reflecting investments in commercial expansion and medical education.
- The company reported a non-GAAP net loss of $13.3 million, or $0.16 per share, indicating ongoing financial challenges despite revenue growth.
- HeartFlow's GAAP net loss was $27.4 million, including a $7.5 million non-cash impairment charge related to facilities optimization.
- The company faces challenges in expanding awareness and adoption of its Plaque Analysis product, with ongoing efforts needed to educate the clinical community and secure payer coverage.
Good day and thank you for standing by. Welcome to the HeartFlow first quarter 2026 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your speaker today, Nick Laudico, Vice President of Investor Relations. Please go ahead.
Good afternoon, everyone, welcome to the HeartFlow first quarter 2026 earnings conference call. Joining me today are John Farquhar, HeartFlowâs President and Chief Executive Officer; and Vikram Verghese, our Chief Financial Officer. Today, we will walk you through our Q1 performance, share updates on our commercial momentum, innovation pipeline, and clinical programs, provide financial guidance.
A live Q&A session will follow. The earnings release accompanying todayâs discussion is available on our investor relations website at ir.heartflow.com. During this call, we will refer to certain non-GAAP financial measures. Reconciliations to the most comparable GAAP figures
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
